| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 2,812,000 | 3,536,000 | 4,110,000 | 3,383,000 | | Cost of Revenue | 927,000 | 1,156,000 | 2,597,000 | 1,039,000 | | | Gross Profit | 1,885,000 | 2,380,000 | 1,513,000 | 2,344,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 969,000 | 1,179,000 | 1,024,000 | 1,111,000 | | Non Recurring | 21,000 | 31,000 | (2,000) | (56,000) | | Others | 342,000 | 706,000 | (476,000) | 785,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 553,000 | 464,000 | 967,000 | 504,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 30,000 | 43,000 | (52,000) | 45,000 | | Earnings Before Interest And Taxes | 575,000 | 498,000 | 946,000 | 543,000 | | Interest Expense | 187,000 | 189,000 | 175,000 | 165,000 | | Income Before Tax | 388,000 | 309,000 | 771,000 | 378,000 | | Income Tax Expense | 122,000 | 75,000 | 277,000 | 83,000 | | Minority Interest |
-
| (18,000) | (60,000) | (47,000) | | | | Net Income From Continuing Ops | 266,000 | 216,000 | 434,000 | 261,000 | | | Non-recurring Events | | Discontinued Operations | 3,000 |
-
| 6,000 | (1,000) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 269,000 | 216,000 | 440,000 | 260,000 | | Preferred Stock And Other Adjustments | (19,000) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $250,000 | $216,000 | $440,000 | $260,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
